-
公开(公告)号:US20200146977A1
公开(公告)日:2020-05-14
申请号:US16609062
申请日:2018-04-27
申请人: Astellas Pharma Inc.
发明人: Yoshiaki Umemoto , Takatsune Yoshida , Sachie Namiki , Akira Takagi , Ryo Kojima , Toshiro Sakai , Shinsuke Oba , Hajime Aoki
IPC分类号: A61K9/00 , A61K9/20 , A61K31/4166
摘要: Provided is a pharmaceutical composition for oral administration in which the solubility and/or dissolution properties of enzalutamide are improved and supersaturation is maintained. Also provided is a pharmaceutical composition for oral administration in which the oral absorbability of enzalutamide is improved. The pharmaceutical composition for oral administration comprises enzalutamide and polyvinyl alcohol.
-
公开(公告)号:US11376328B2
公开(公告)日:2022-07-05
申请号:US16609029
申请日:2018-04-27
申请人: Astellas Pharma Inc.
发明人: Takatsune Yoshida , Hiroyuki Kojima , Yoshiaki Umemoto , Sachie Namiki , Akira Takagi , Ken Shimada
IPC分类号: A61K47/32 , A61K31/4245 , A61K31/439 , A61K31/4422
摘要: Provided is a pharmaceutical composition in which the solubility and/or dissolution properties of a poorly-soluble drug can be improved. The pharmaceutical composition comprises a poorly-soluble drug, and polyvinyl alcohol having a saponification degree of 63 mol % or more and 67 mol % or less.
-